NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...
NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE ... companies adhere to responsible business practices and engage ...
NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE ... companies adhere to responsible business practices and engage in ...
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein ... notifies investors that a class action lawsuit has been filed against GSK plc (“GSK” or “the Company”) (NYSE: GSK) and ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK ... Competition with the leading companies in the anti-obesity business, which is expected to grow to $130 billion by ...
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK ... or other unlawful business practices.
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE ... concentrating its practice in securities class actions ...
Core profits per share (EPS) increased by 12% as well. GSK plc (NYSE:GSK)’s Specialty Medicines business saw a 19% increase in sales, which was credited with this success. Its oncology revenues ...